Clinical Trial Update: Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two formulations of triptorelin (3-month vs 1-month) in Chinese subjects with endometriosis completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• triptorelin acetate PR 1-month (triptorelin acetate)
• triptorelin pamoate PR 3-month (triptorelin pamoate)

Snippet

Sponsor: Ipsen | Conditions: Endometriosis | Phase 3 | Status: COMPLETED | Results posted: 2021-10-14